Strategic Partnership Resonetics integration opportunity combines energy source and pulse-generator capabilities for neuromodulation, BCI, and CRM markets, enabling a comprehensive offering to customers and expanding MED-ALLY's addressable system scope.

Expansion Potential Past growth in Goose Creek facility with significant job creation indicates capacity for scale; target customers may include large medical device assemblers and contract manufacturers seeking capacity and regional expansion.

VersaStim Platform VersaStim 16+ channel platform offers rapid customization to meet therapeutic requirements, presenting a compelling value proposition for hospitals and clinics seeking adaptable neuromodulation and bioelectronic solutions.

Financial Entry Current revenue range suggests a growing mid-market company; propose pilot programs or co-development deals with larger medical device players to accelerate revenue growth and validate the platform.

Market Positioning Focus on implantable neuromodulation and multiparameter systems positions MED-ALLY to capture demand from neuromodulation, BCI, and CRM markets; target strategic customers in energy-efficient device manufacturing and turnkey integration.